BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Piñero F, Marciano S, Fernández N, Silva J, Anders M, Zerega A, Ridruejo E, Romero G, Ameigeiras B, D’Amico C, Gaite L, Bermúdez C, Reggiardo V, Colombato L, Gadano A, Silva M. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis. World J Gastroenterol 2019; 25(27): 3607-3618 [PMID: 31367160 DOI: 10.3748/wjg.v25.i27.3607]
URL: https://www.wjgnet.com/1948-5182/full/v25/i27/3607.htm
Number Citing Articles
1
Federico Piñero, Marcelo Silva, Massimo Iavarone. Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitorsWorld Journal of Gastroenterology 2020; 26(16): 1888-1900 doi: 10.3748/wjg.v26.i16.1888
2
Claudia Maccali, Aline L. Chagas, Ilka Boin, Emilio Quiñonez, Sebastián Marciano, Mario Vilatobá, Adriana Varón, Margarita Anders, Sergio Hoyos Duque, Agnaldo S. Lima, Josemaría Menendez, Martín Padilla‐Machaca, Jaime Poniachik, Rodrigo Zapata, Martín Maraschio, Ricardo Chong Menéndez, Linda Muñoz, Diego Arufe, Rodrigo Figueroa, Alejandro Soza, Martín Fauda, Simone R. Perales, Rodrigo Vergara Sandoval, Carla Bermudez, Oscar Beltran, Isabel Arenas Hoyos, Lucas McCormack, Francisco Juan Mattera, Adrián Gadano, Jose H. Parente García, Claudia Megumi Tani, Luiz Augusto Carneiro D’Albuquerque, Flair J. Carrilho, Marcelo Silva, Federico Piñero. Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohortLiver International 2021; 41(4): 851 doi: 10.1111/liv.14736
3
Cecilia C. Garcia, Bárbara Piotrkowski, Plácida Baz, Daniel Poncino, Javier Benavides, Luis Colombato, María Laura Reyes Toso, Silvina Yantorno, Valeria Descalzi, Gabriel E. Gondolesi, Cesar G. Fraga, Alejandra C. Cherñavsky. A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences 2021;  doi: 10.1007/s10620-021-07105-z
4
Federico Piñero, Mario Tanno, Gabriel Aballay Soteras, Matías Tisi Baña, Melisa Dirchwolf, Eduardo Fassio, Andrés Ruf, Silvia Mengarelli, Silvia Borzi, Nora Fernández, Ezequiel Ridruejo, Valeria Descalzi, Margarita Anders, Guillermo Mazzolini, Virginia Reggiardo, Sebastián Marciano, Florencia Perazzo, Juan Carlos Spina, Lucas McCormack, Martín Maraschio, Cecilia Lagues, Adrián Gadano, Federico Villamil, Marcelo Silva, Fernando Cairo, Beatriz Ameigeiras. Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinomaAnnals of Hepatology 2020; 19(5): 546 doi: 10.1016/j.aohep.2020.06.003
5
Laura L de Guevara, Lucy Dagher, Vanessa MV Arruda, Keiko Nakajima, Masatoshi Kudo. Sorafenib treatment by Child–Pugh score in Latin American patients with hepatocellular carcinomaFuture Oncology 2020; 16(31): 2511 doi: 10.2217/fon-2020-0323
6
Hong Zhao, Aiping Zhou, Jianguo Zhou, Xinyu Bi, Shida Yan, Jing Jin, Wenqiang Wei, Muxing Li, Caifeng Gong, Qichen Chen, Zhiwen Luo, Ning Li, Rui Mao, Xiao Chen, Bo Chen, Rongshou Zheng, Jianjun Zhao, Yue Han, Zhiyu Li, Xu Che, Yuan Tang, Yongkun Sun, Zhen Huang, Yefan Zhang, Xiaoying Wang, Yubao Zhang, Zhenhui Lu, Xiaowei Dang, Tianqiang Song, Chang Liu, Ping Yue, Dong Yan, Aimin Yue, Rui Zhang, Suxia Luo, Jing Tan, Xuewen Zhang, Xueli Bai, Xuejun Zhang, Mingyan He, Yujun Xie, Wenling Wang, Po Yang, Yijun Yang, Yamin Zhang, Qingdong Li, Tao Peng, Zusen Wang, Yajin Chen, Changzhen Shang, Yingjian Liang, Bixiang Zhang, Feng Zhang, Liming Wang, Duo Li, Bin Liu, Xiaofeng Zhu, Qinggang Hu, Minshan Chen, Dianrong Xiu, Feng Xia, Yanqiao Zhang, Yong Zeng, Yilei Mao, Xun Li, Yi Ba, Tingbo Liang, Feng Shen, Lianxin Liu, Xiujun Cai, Jian Zhou, Jianqiang Cai. Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter surveyHPB 2021;  doi: 10.1016/j.hpb.2021.07.002
7
Juanfang Liu, Zhen Li, Wenguang Zhang, Huibin Lu, Zhanguo Sun, Guozheng Wang, Xinwei Han. Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma PatientsFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.709060
8
Juan Ignacio Marín-Zuluaga, Juliana Vergara-Cadavid, Liliana Cajiao-Castro, Danny Arroyave-Zuluaga, Susana Castro-Sánchez, Laura Ceballos-Ramírez, Octavio Muñoz-Maya, Gabriel Sebastián Díaz-Ramírez. Caracterización, manejo y pronóstico de una cohorte de pacientes cirróticos con carcinoma hepatocelular. Hospital Pablo Tobón Uribe 2012-2018Hepatología 2020; : 134 doi: 10.52784/27112330.121
9
Federico Piñero, Leonardo Gomes da Fonseca. Trial eligibility in advanced hepatocellular carcinoma: Does it support clinical practice in underrepresented subgroups?World Journal of Gastroenterology 2021; 27(24): 3429-3439 doi: 10.3748/wjg.v27.i24.3429
10
Ying Jia, Yufei Xing, Meitian Yang, Muhammad Wasim Khan. Efficacy of Sorafenib Combined with Interventional Therapy on Primary Liver Cancer Patients and Its Effect on Serum AFP, VEGF, and GGTJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9120265